Authors:
PELTEKIAN KM
BAILEY R
BAIN V
MA M
SHERKER A
STALGIS C
Citation: Km. Peltekian et al., HEPATITIS-C GENOTYPE-1 (HCV G-1) VIRAL KINETICS DURING COMBINATION THERAPY WITH RIBAVIRIN (RIB) AND VARIOUS INDUCTION DOSES OF INTERFERON-ALPHA (IFN), Hepatology, 28(4), 1998, pp. 196-196
Authors:
LURIE Y
ESTEBANMUR R
BUTI M
ESTEBANMUR JI
STALGIS C
Citation: Y. Lurie et al., DAILY THERAPY FOR 12 WEEKS WITH IFN-ALPHA-2B PLUS RIBAVIRIN IN NONRESPONDERS WITH HCV-RNA GENOTYPE-1, Hepatology, 28(4), 1998, pp. 489-489
Authors:
VUCELIC B
PELTEKIAN K
LAURIE Y
VAFIADES I
STALGIS C
Citation: B. Vucelic et al., 4 WEEKS OF DAILY IFN PLUS RIBAVIRIN THERAPY IS INSUFFICIENT TO MAINTAIN VIRAL SUPPRESSION IN HCV-RNA GENOTYPE-1 PATIENTS, Hepatology, 28(4), 1998, pp. 490-490
Authors:
TSANTOULAS D
VAFIADES J
KRONBORG I
LURIE Y
VECELIC B
STALGIS C
Citation: D. Tsantoulas et al., 4 WEEKS OF DAILY THERAPY WITH IFN-ALPHA-2B PLUS RIBAVIRIN FOLLOWED BYSTANDARD THERAPY IN GENOTYPE-3 - RESULTS AT 12 WEEKS, Hepatology, 28(4), 1998, pp. 1263-1263
Authors:
BUTI M
OLIVE G
ESTEBAN JJ
STALGIS C
DORAN Z
ESTEBAN R
Citation: M. Buti et al., GENOTYPE-1 NONRESPONDER PATIENTS TREATED WITH HIGH DAILY IFN-ALPHA 2BPLUS RIBAVIRIN (R) DOSES ACHIEVE RAPID AND PROFOUND VIRAL REDUCTION, Hepatology, 26(4), 1997, pp. 351-351